ILMN Trading Analysis - 10/22/2026 03:32 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge of Illumina (ILMN) and are provided for contextual background only, separate from the data-driven analysis below.

• Illumina announced continued ramp in NovaSeq X sequencing instrument placements, supporting long-term genomic revenue visibility.
• Regulatory overhang from ongoing EU and US antitrust scrutiny of the Grail divestiture remains a potential catalyst.
• Recent industry conferences highlighted softening academic research budgets, a concern for instrument consumables demand.
• No confirmed near-term earnings date in provided data; historical fiscal year end was 2025-12-01 per fundamentals.
• Headlines suggest fundamental recovery narrative, which contrasts with bearish options sentiment seen in embedded data.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ILMN:

• Trailing P/E is 49.60 with trailing EPS of 5.40; no forward P/E, PEG, or revenue growth data provided.
• Market cap is 39,711,490,000.00 with 151,000,000.00 shares outstanding and dividend yield of 0.00.
• Beta is 1.11 (moderately above market); 52-week high 309.35 and low 94.00; current price near high end.
• Institutional ownership is 79.81%, average volume 2,748,000.00, historical volatility 55.08%.
• Key missing fields: profit margins, ROE, debt/equity, free cash flow, revenue, analyst target all null.
• Fundamentals show premium valuation (P/E 49.60) with no growth/margin data to confirm alignment to technicals.

Current Market Position

Current price per indicators is 284.44 (as of 2026-10-21 close). Minute bars show 2026-10-21 open 267.35, high 286.40, low 263.28, close 284.44. On 2026-10-22 last bar close was 262.05 with low 262.05, indicating late-session weakness.

Intraday 2026-10-21 opened weak at 267.35 then rallied to 286.40 by midday; 2026-10-22 faded to 262.05 by 15:00. Volume on 2026-10-21 was 1,717,286 vs 20-day avg 1,909,873.

Technical Analysis

Price 284.44 is above SMA 5 (269.49), SMA 20 (272.23), and SMA 50 (238.80) – bullish alignment. RSI 57.63 shows moderate momentum, not overbought. MACD histogram positive 1.86 indicates mild bullish momentum. Bollinger mid 272.23, price near upper 286.82 (range expansion). 30-day high 309.35, low 200.01; price in upper third. ATR 15.66 shows elevated volatility.

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bearish. Call dollar volume 343,630.00 (26.60%), Put dollar volume 946,790.00 (73.40%), total 1,290,420.00. Put contracts 433 vs call 159. Sentiment derived from delta 40-60 only (21 of 574).

Pure directional positioning shows strong put conviction. Divergence: technicals bullish-aligned, sentiment bearish per option spread advice "Wait for alignment".

Key Price Levels (observational only)